COVERAGE
Exclusive: How McDermott is Piloting Three AI Tools
October 8, 2024
Read time: 2 min

COVERAGE
October 8, 2024
Read time: 2 min

COVERAGE
October 8, 2024
Read time: 2 min

DEAL ANNOUNCEMENT / PRESS RELEASE
October 7, 2024
Read time: 3 min
International law firm McDermott Will & Emery advised LetsGetChecked, a leading global healthcare solutions company, in its acquisition of Truepill, a leading digital pharmacy platform. With this acquisition, LetsGetChecked bolsters its ability to help partners provide a more seamless healthcare journey, while ensuring high-quality care and a better health management experience for patients.
The McDermott team was led by Lisa Mazur and Mary Waller with invaluable support from Travis Jackson, Sarah Kitchell, Grayson Dimick, James Cannatti, Sam Siegfried and Danielle Scheer.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

DEAL ANNOUNCEMENT
7. Oktober 2024
Read time: 3 min
Chicago/Frankfurt/München, 7. Oktober 2024 – McDermott Will & Emery hat SubjectWell, einen US-amerikanischen Anbieter von digitalen Lösungen zur Patientenrekrutierung, bei der Übernahme von Trials24 beraten. Diese strategische Partnerschaft wird Patienten weltweit Zugang zu innovativen Behandlungsformen bieten.
Trials24 mit Hauptsitz in München beschleunigt die Patientenrekrutierung für klinische Studien weltweit und hilft CROs und biopharmazeutischen Unternehmen, Patienten zu finden, die nicht in Reichweite ihrer Standorte sind.
SubjectWell ist ein Portfoliounternehmen von Windrose Health Investors. Windrose investiert in Unternehmen, die auf Dienstleistungen in der Gesundheitsbranche spezialisiert sind, und hatte SubjectWell im April 2024 erworben.
Weitere Informationen in der Pressemitteilung von SubjectWell.
McDermott Will & Emery: Holger Ebersberger (München), Dr. Felix Ganzer (Frankfurt; beide Federführung), Jarrett Szczesny (Chicago; alle Private Equity), Jana Grieb (Healthcare), Dr. Christian Rolf (Arbeitsrecht), Dr. Florian Schiefer (Steuern; alle Frankfurt), Dr. Claus Färber (Counsel, IT, München); Associates: Dr. Armin Teymouri (Private Equity, München), Dr. Lea Hachmeister (Healthcare), Constanze Götz (Öffentliches Recht; beide Frankfurt), Janek Joosten (Arbeitsrecht, Düsseldorf)

COVERAGE
October 7, 2024
Read time: 2 min

DEAL ANNOUNCEMENT / PRESS RELEASE
October 1, 2024
Read time: 3 min
Frankfurt a.M., October 1, 2024 – McDermott Will & Emery is strengthening its German investment funds practice with the addition of lawyer Ilka Breuer. She will join McDermott’s Frankfurt office as Counsel on October 1, 2024.
Ilka Breuer has more than 20 years of experience in the areas of investment funds and asset management. She regularly advises investment companies and asset managers as well as institutional investors from Germany and abroad and also represents them vis-à-vis national and European supervisory authorities.
Ilka Breuer joins McDermott from Ashurst. From 2012 to 2020, she worked for the German Investment and Asset Management Association (BVI) in the legal department. She began her career as a lawyer at Clifford Chance.
‘With her extensive experience in investment funds and asset management, llka Breuer is an excellent addition to our team,’ says Frank Müller, Managing Partner of McDermott’s Frankfurt office. ‘We warmly welcome her to our firm.’

COVERAGE
October 6, 2024
Read time: 2 min

COVERAGE
October 4, 2024
Read time: 2 min

DEAL ANNOUNCEMENT / PRESS RELEASE
October 1, 2024
Read time: 3 min
International law firm McDermott Will & Emery represented H.I.G. Capital, LLC (H.I.G.), a leading global alternative investment firm with $65 billion of capital under management, as its affiliate acquired SkinCure Oncology Intermediate LLC (SkinCure Oncology).
SkinCure Oncology provides its physician partners with a noninvasive model when conducting IG-SRT for the treatment of nonmelanoma skin cancer.
The McDermott team was led by Alex Clavero and Jun Won Kim with invaluable support from Nate Wolfe, Michael Kim, Ryan Forman and Chris McCarthy.
McDermott’s private equity (PE) practice is among the top four most active PE law firms globally and in the US with more than 160 dedicated PE lawyers across 21 locations. We have ranked Pitchbook’s Top 5 Healthcare PE firm for six consecutive years and are Top 10 in PE Buyouts and other PE deals. We are also ranked as a Top 10 Global Mid-Market PE Firm by Bloomberg and #7 PE Law firm by The Deal. Learn more about our PE practice by visiting pe.mwe.com.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

COVERAGE
October 1, 2024
Read time: 2 min